Cargando…
Association of chronic neutrophil activation with risk of mortality
BACKGROUND: Levels of free myeloperoxidase (MPO), a cardiovascular risk marker, have been reported to decline with standard care. Whether such declines signify decreased risk of mortality remains unknown. DESIGN: Cox proportional hazard models were generated using data from a retrospective cohort st...
Autores principales: | Penn, Marc S., MacRae, Calum, Goldfaden, Rebecca F., Choksi, Rushab R., Smith, Steven, Wrenn, David, Saghir, Mouris X., Klemes, Andrea B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358907/ https://www.ncbi.nlm.nih.gov/pubmed/37471318 http://dx.doi.org/10.1371/journal.pone.0288712 |
Ejemplares similares
-
A Review on the Efficacy and Safety of Oral Semaglutide
por: Niman, Stephanie, et al.
Publicado: (2021) -
A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data
por: Rana, Khyatiben, et al.
Publicado: (2019) -
SGLT-2 inhibitors and their potential in the treatment of diabetes
por: Rosenwasser, Rebecca F, et al.
Publicado: (2013) -
Knowledge of an inflammatory biomarker of cardiovascular risk leads
to biomarker-based decreased risk in pre-diabetic and diabetic
patients
por: Alcivar-Franco, Diego, et al.
Publicado: (2018) -
Parsing cell death in arrhythmogenic cardiomyopathy:
PANoptosis
por: MacRae, Calum A.
Publicado: (2023)